Pages that link to "Q24815846"
Jump to navigation
Jump to search
The following pages link to Survivin expression and its clinical significance in pancreatic cancer (Q24815846):
Displaying 31 items.
- Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells (Q31109734) (← links)
- Angiopoietin 2 induces astrocyte apoptosis via αvβ5-integrin signaling in diabetic retinopathy (Q33586788) (← links)
- YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells (Q33626354) (← links)
- Biological approaches to therapy of pancreatic cancer (Q33899938) (← links)
- Nuclear receptors and pathogenesis of pancreatic cancer. (Q34168476) (← links)
- Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth (Q34334258) (← links)
- Survivin and pancreatic cancer (Q35000802) (← links)
- Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model (Q35073199) (← links)
- Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer (Q35101161) (← links)
- Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells (Q35777871) (← links)
- Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer (Q36078792) (← links)
- Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors (Q36092777) (← links)
- High expression of survivin is prognostic of shorter survival but not predictive of adjuvant gemcitabine benefit in patients with resected pancreatic adenocarcinoma (Q36796262) (← links)
- RETRACTED: 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer (Q37345627) (← links)
- Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol (Q37601058) (← links)
- Molecular changes in pancreatic cancer (Q37614592) (← links)
- Current research in perineural invasion of cholangiocarcinoma (Q37706677) (← links)
- Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis (Q37858851) (← links)
- Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer (Q37885319) (← links)
- Pancreatic stellate cells increase pancreatic cancer cells invasion through the hepatocyte growth factor /c-Met/survivin regulated by P53/P21. (Q38810395) (← links)
- YM155 induces apoptosis through downregulation of specificity protein 1 and myeloid cell leukemia-1 in human oral cancer cell lines (Q38932250) (← links)
- An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma. (Q39703281) (← links)
- siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity (Q39966187) (← links)
- Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity in glioma cells (Q40025062) (← links)
- Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines. (Q47106034) (← links)
- Plectin-1 Targeted Dual-modality Nanoparticles for Pancreatic Cancer Imaging (Q51735492) (← links)
- CRM1/XPO1 expression in pancreatic adenocarcinoma correlates with survivin expression and the proliferative activity. (Q55386332) (← links)
- An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer (Q57038074) (← links)
- The effect of perineural invasion on overall survival in patients with gastric carcinoma (Q81234870) (← links)
- Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo (Q83309777) (← links)
- Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors (Q90032269) (← links)